OpenResearchAlpha

JAMA Health Forum · 6 Nov 2026

State Medicaid Programs' Formulary Preference for Brand-Name Over Generic Drugs

Sarah M. E. Gabriele, Aaron S. Kesselheimh-index 53, Benjamin N. Rome

0
Citations
no database records one yet
0
Citations in 2026
so far
53
Leading author's h-index
Aaron S. Kesselheim, in QAI's scholar index
7
References
works it cites, from open citation data

Citations by database

Each database indexes a different set of journals, preprints and books, so they are shown side by side rather than blended.

  • OpenCitations0
  • Crossref0
  • Europe PMC0

Citations per year

The current year is still counting.

  • 2026 so far0

Abstract

This cross-sectional study explores the use of the brand-over-generic designation in the state Medicaid program formulary.

What the data shows

  • No database records a citation yet, as is usual for a paper this new.
  • Aaron S. Kesselheim has the highest h-index among the authors (53).

Graph

This paper in the middle, its authors and their most-cited papers below, the papers it cites to the left and the papers citing it to the right. The timeline lays every paper out by year.

Citing paper shares an authorAuthor without a profileSize shows citations, or h-index for authors

Select a node for its details. Drag to pan, scroll to zoom, drag a node to move it.

Start with

Authors (3)

Each author's standing in QAI's scholar index: the works their ORCID iD is attached to, and for anyone whose ORCID record names a lab OpenResearch follows, their arXiv preprints matched by name and a shared co-author. Names are as printed on the paper.

ProfileMost-cited paper

Cited by 0 papers

Who cites this paper, from open citation data, with Crossref's record of each; the 100 newest when there are more.

0 shown
No citing papers for this filter.

References (7)

What it cites, from open citation data, with Crossref's record of each.